July 13, 2023
Two CNA units had no duty to defend a generic-drug maker against a rival's suit, but cannot seek reimbursement of defense costs based on a reservation of rights letter, the Eleventh Circuit affirmed in a published opinion Thursday.
October 28, 2021
Generic-drug maker Winder Laboratories told the Eleventh Circuit on Thursday to uphold a ruling finding that it doesn't need to pay two of its insurers back for costs they incurred defending Winder against a rival company's false advertising suit.
September 01, 2021
Two insurers told the Eleventh Circuit that they're entitled to costs they incurred defending a generic drugmaker against a rival's suit, saying their suit will help resolve a novel issue in Georgia over a carrier's reservation of rights to recoup defense costs.